Angiogenesis is known to be a fundamental factor in the local growth of tumors and in progression with metastases, and is most commonly assessed by measuring either the expression of vascular endothelial growth factor (VEGF) in cancer cells or tumor CD31- or CD34-positive microvessel density (MVD). Here, VEGFA is linked to neoplasm.